By Frank Prenesti
Date: Thursday 16 Jun 2022
LONDON (ShareCast) - (Sharecast News) - Healthcare investment company Syncona reported flat year-end net assets of £1.31bn in its final results on Thursday.
The FTSE 250 firm said that made for net assets per share of 194.4p as at March 31, rising from 193.9p, making for a net asset value total return of 0.3%, down from 4.4% last year.
It said its life science portfolio was valued at £525m, down from £722.1m at year-end, making for a return of 0.8%.
"The business is well positioned to create a diversified portfolio of 15-20 companies with a goal of delivering three to five companies in which we retain a significant ownership interest to the point of product approval on a rolling 10-year basis," Syncona said on Thursday.
"We believe if we achieve this goal, we will deliver transformational outcomes for patients and strong risk-adjusted returns for shareholders."
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 110.20p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 162.20 |
52 Week Low | 106.20 |
Volume | 0 |
Shares Issued | 651.27m |
Market Cap | £717.70m |
RiskGrade | 291 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 21-Jun-18 | 20-Jul-17 |
Paid | 30-Jul-18 | 23-Aug-17 |
Amount | 2.30p | 2.30p |
You are here: research